Fulltext

Whole genome sequencing as a means to assess pathogenic mutations in medical genetics and cancer

Royer-Bertrand, Beryl ; Rivolta, Carlo

In: Cellular and Molecular Life Sciences, 2015, vol. 72, no. 8, p. 1463-1471

Ajouter à la liste personnelle
    Titre
    • Whole genome sequencing as a means to assess pathogenic mutations in medical genetics and cancer
    Auteur
    • Royer-Bertrand, Beryl. Department of Medical Genetics, University of Lausanne, Rue Du Bugnon 27, 1005, Lausanne, Switzerland
    • Rivolta, Carlo. Department of Medical Genetics, University of Lausanne, Rue Du Bugnon 27, 1005, Lausanne, Switzerland
    Type de document
    • Postprint
    Langue
    • Anglais
    Publié dans
    • Cellular and Molecular Life Sciences, 2015, vol. 72, no. 8, p. 1463-1471. Springer Basel
    Autre version électronique
    Identifiant OAI-PMH
    • oai:doc.rero.ch:332149
    Summary
    The past decade has seen the emergence of next-generation sequencing (NGS) technologies, which have revolutionized the field of human molecular genetics. With NGS, significant portions of the human genome can now be assessed by direct sequence analysis, highlighting normal and pathological variants of our DNA. Recent advances have also allowed the sequencing of complete genomes, by a method referred to as whole genome sequencing (WGS). In this work, we review the use of WGS in medical genetics, with specific emphasis on the benefits and the disadvantages of this technique for detecting genomic alterations leading to Mendelian human diseases and to cancer.